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Results The overall level of obesity among Egyptian women rises
from 30% in 1995 (urban¼33%; rural¼27%) to 40% in 2008
(urban¼43%; rural¼34%). Among urban women, in 1995, the
prevalence of obesity is lower in the group without education (24%;
95% CI 19 to 29) in comparison to the group with secondary
education (33%; 95% CI 29 to 37). In 2008, the prevalence of obesity
has risen in a statistically signiﬁcant manner in both groups
compared with 1995. In addition, the prevalence in the group
without education (45%; 95% CI 41 to 50) appears to have exceeded
the prevalence in those with secondary education (41%; 95% CI 38
to 44). Although there is overlap in the CI at the 95% level, the
overall trend suggests that the social gradient in obesity may be
reversing, as predicted elsewhere.
Conclusion Egypt provides a dynamic model of the reversal of the
social gradient of obesity. Further analysis of Demographic and
Health Surveys using other indicators of socio-economic status and
risk factors for obesity such as consumption of fruit and vegetables
may shed light on the processes behind the probable gradient
reversal, and the factors putting the poor at increased risk of obesity.
This is important in informing urgent prevention efforts at a
population level.
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Objective This project aims to: (1) describe the frequency of news
coverage in mass media related to the National Institute for Health
and Clinical Excellence (NICE) draft or ﬁnal guidance; (2) analyse
the types of evidence and sources of information that was quoted in
the news; (3) compare whether the patterns of coverage differ
between media.
Design A survey of news articles related to decisions made by
NICE’s Health Technology Appraisal committees was conducted.
Relevant news articles were retrieved from websites of major UK
news media. Inclusion criteria were: (1) news articles related to
speciﬁc NICE decision(s); (2) articles were written by a reporter/
writer/editor of the news media. Articles that mentioned NICE for
other reasons, columns and readers’ letters were excluded.
Setting Major UK news media, including national newspapers and
news channels.
Samples News articles published during 2007e2008 in 13 different
sources of media including tabloids (Daily Express, Daily Mail,
News of the World, The Mirror, The Sun), broadsheets (Inde-
pendent, Guardian, The Telegraph, The Times) and news channels
(BBC, ITN, Sky News and Reuters).
Main outcome measure The following data were collected by one
author and checked by another: nature of guidance (disease area;
positive or negative recommendation), use of generic or brand name
and source/type of evidence that was quoted. Descriptive statistics
were compiled and comparisons between types/sources of news
media were made using c2 test.
Results 329 articles were included. BBC, Daily Mail and The Tele-
graph published more than 50 articles related to health technology
appraisal whereas ITN and News of the World published less than
10 articles during the 2-year period assessed. Two-thirds (220/329) of
the articles were related to negative recommendations. There was
signiﬁcant difference in the proportion of articles relating to nega-
tive recommendations between individual sources of media
(p¼0.001) but not between types of media (p¼0.286). Cancer (33%),
neurologyemainly Alzheimer ’s disease (22%), ophthalmology
(13%) and rheumatology (10%) were most frequently covered areas.
58% (192/329) of the articles quoted only brand names without
mentioning generic names of the drugs. Approximately 50% of
articles included statements of effectiveness without referring to the
source of evidence and another 40% did not describe clinical effec-
tiveness. 24% of articles did not mention drug costs or cost-effec-
tiveness.
Conclusion NICE decisions on new drugs, particularly negative
recommendations, attracted signiﬁcant media attention but the
coverage and contents varied substantially between individual
sources.
051 A POLICY EFFECTIVENESS-FEASIBILITY LOOP? PROMOTING
THE USE OF EVIDENCE TO SUPPORT THE DEVELOPMENT OF
HEALTHY PUBLIC POLICY
doi:10.1136/jech.2010.120956.51
1N Unwin, 2K Bennett, 3S Capewell, 1J Critchley, 4F Fouad, 5A Husseini, 3M O’Flaherty,
4,6W Maziak, 7A Mataria, 1P Phillimore, 8H B Romdhane, 9B Unal, 1S Zaman. 1Institute
of Health and Society, Newcastle University, Newcastle-upon-Tyne, UK; 2Trinity Centre
for Health Sciences, St James’s Hospital, Dublin, Republic of Ireland; 3Department of
Public Health, University of Liverpool, Liverpool, UK; 4Syrian Center for Tobacco
Studies, Aleppo, Syria; 5Institute of Community and Public Health, Birzeit University,
Palestine; 6School of Public Health, University of Memphis, Memphis, Tennessee, USA;
7Health Economics and Health Care Financing Unit, Division of Health Systems and
Service Delivery, World Health Organization-Eastern-Mediterranean Regional Office,
Cairo, Egypt; 8CVD Epidemiology and Prevention Research Laboratory, National Public
Health Institute, Tunis, Tunisia; 9Department of Public Health, School of Medicine,
Dokuz Eylul University, Turkey
Background Historically, policy initiatives have made variable
contributions to improvements in public health. Today there is a
growing interest in translating evidence from health research into
healthy public policy. Although research evidence may be a
component of policy development, it is rarely enough, because
policy makers are subject to a wide range of inﬂuences. Furthermore,
researchers and policy makers usually work within different time
frames and rules of evidence. There is a growing, albeit limited,
literature on how researchers can most effectively engage with
policy makers. Evidence suggests that more active and effective
dialogue between researchers and policy makers is needed, in the
formulation of research questions, presentation of evidence, and
drafting and choice of policy options.
Aim To develop, implement, and evaluate an interactive approach to
informing policy for the prevention and management of cardiovas-
cular disease (CVD) and diabetes.
Setting This work is being undertaken in four eastern Medi-
terranean territories, known to have high burdens of CVD and
diabetes: Palestine, Tunisia, Turkey and Syria.
Methods and results Available epidemiological data are being iden-
tiﬁed, appraised and used to populate the IMPACT CHD Policy
Model in order to examine CHD trends. Two corresponding epide-
miological models have been developed to examine trends in type 2
diabetes and ischaemic stroke. An intensive review of the literature
and consultation assists in the identiﬁcation of efﬁcacious policy
interventions. A situation analysis is being undertaken within each
country using mixed methods, which include: key informant and in
depth interviews, document reviews, and participant observation.
Its aim is to review current policy (stated and implemented),
perceived facilitators and barriers to policy change, including health
beliefs, and aspects of the health system. Policy makers are explicitly
involved as key informants, participants, advisors and “lobbyists”.
The epidemiological modelling, evidence based reviews, and situa-
tion analyses are together being used to generate diverse policy
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options. The cost-effectiveness of each chosen option will then be
assessed.
Conclusions We have developed a provisional framework for devel-
oping policy options, initially for the prevention of CVD and
diabetes. This is based on local epidemiological data, an assessment
of the socio-political-cultural context and cost effectiveness. Policy
makers are involved throughout, and will be presented with costed
policy options along with their potential consequences. Imple-
mented options will then be evaluated. The framework represents a
“policy effectiveness-feasibility loop”, analogous to Tugwell’s clinical
effectiveness loop. The impact of this approach, and its potential
generalisability, will be rigorously evaluated.
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Objective To review: the process of public health policy-making;
variations in the extent of research evidence used; other inﬂuencing
factors; and barriers to and facilitators of the use of research
evidence.
Design Systematic review of empirical studies reporting data on
policy-making in public health.
Data Sources Databases searched: MEDLINE, SCOPUS, PsychInfo,
CINAHL, The Social Science Citation Index, The Science Citation
Index, The Arts and Humanities Citation Index, Applied Social
Sciences Index and Abstracts, Database of Reviews of Effects,
Cochrane Database of Systematic Reviews, DoPHER, the Campbell
Library, and the Cochrane Register of Controlled trials. Other
sources: screening of organisational websites, contacting key
informants and scrutinising the bibliographies of included studies.
Review methods Two reviewers independently assessed studies for
inclusion; extracted data and assessed methodological quality using
predesigned forms. Disagreements were resolved by consensus or by
recourse to a third reviewer. Data were synthesised as a narrative
review.
Results 1216 articles were retrieved. Following screening 18 studies
were included: 13 qualitative studies, four surveys and one literature
review. Participants included 1200 policy-makers, 72 researchers,
and 174 people involved in both activities. Studies were set in a
range of country and policy-making settings. Methodological
quality was mixed. The process of policy-making varies widely
between settings, and is viewed differently by key players. An
extensive range of types of research evidence are used in policy-
making. However, it has only an indirect impact and competes with
many other inﬂuences. Barriers to the use of research evidence are
well-described and include: policy-makers’ perceptions of research
evidence; the gulf between researchers and policy-makers; the
culture in which policy-makers work; competing inﬂuences on
policy-making; and practical constraints. Ways of overcoming these
barriers are less well known, and include: research targeted at the
needs of policy-makers; research clearly highlighting key messages;
and capacity building. There is almost no evidence on the role of
research evidence in addressing health inequalities, a key aim of
public health policy.
Conclusions Action is required by both policy-makers and
researchers to address the barriers identiﬁed in this systematic
review. There is an urgent need for evidence on the best approaches
to incorporating research evidence in public health policy,
particularly that considering the complex effects on health
inequalities.
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Objectives To assess the effect of social spending on population
health.
Design Multivariate regression analysis was performed to inves-
tigate the relationship between age-standardised cause-speciﬁc
mortality rates and social spending. Mortality data were collected
from the European Health for All Database 2009 edition. Social
spending per capita in purchasing-power-parity were taken from the
OECD Social Expenditure Database (including family support, old-
age pensions, healthcare, unemployment beneﬁts, active labour
market programmes, and support for people with disabilities). These
relationships were compared with gross domestic product per capita
(GDP), general government spending per capita (including prisons,
education and defence), and healthcare spending per capita. Models
also included controls for country- and period-ﬁxed effects and
expenditure was adjusted for inﬂation and purchasing power parity.
Setting 13 EU countries, 1980e2003: Belgium (only to 1998),
Denmark, Finland, France, Germany, Greece, Ireland, Italy, Nether-
lands, Spain, Sweden and the UK.
Participants n/a.
Main outcome measure Age-standardised all-cause and cause-speciﬁc
mortality rates.
Results Each additional US$100 increase in social spending per
capita is signiﬁcantly associated with a 0.99% reduction in all-cause,
age-standardised mortality rates (p<0.001). Healthcare spending per
capita had no effect on all-cause mortality rates. Consistent with
previous ﬁndings, we observed each US$100 increase in GDP was
associated with a 0.28% fall in all-cause mortality rates (p<0.001),
about one-fourth of the magnitude of the association of social
welfare with mortality. After adjusting for social welfare spending,
the association of GDP with all-cause mortality was reduced by over
half (b¼0.11%, p¼0.004). Healthcare spending was not associated
with mortality. However, higher social welfare spending was
signiﬁcantly associated with reductions in alcohol-related deaths,
cardiovascular disease and tuberculosis; ﬁndings which are biolog-
ically plausible.
Conclusion Reducing social spending could increase mortality rates.
The majority of the beneﬁts of wealth to health appears to be
determined by the extent to which resources are invested in social
welfare and healthcare systems. Investments in social protection
seem to have greater protective effects on health than investments
in health care. Stronger links between health and labour ministries
offer an opportunity to take advantage of such positive synergies,
especially important to protecting health during times of austerity.
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Background and Objectives In the US, Hispanic mothers have rates
of infant mortality and low birthweight that are comparable to non-
Hispanic White mothers despite being more likely to live in socio-
economically deprived areas. This well known phenomenon is
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